What is the current Bovine Mastitis market size?

The Bovine Mastitis market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Bovine Mastitis market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Bovine Mastitis market?

Increasing demand for milk and dairy products drives the Bovine Mastitis market.

What are the major challenges faced by the Bovine Mastitis market?

Antibiotic resistance and high treatment costs are significant challenges.

Which regions are the leaders in the Bovine Mastitis market?

North America and Europe are the leading regions in the Bovine Mastitis market.

Who are the top companies in the Bovine Mastitis market?

Top companies include Zoetis, Merck, and Elanco Animal Health.

What are the future opportunities in the Bovine Mastitis market?

Growing demand for dairy products in Asia Pacific presents future opportunities.

How does technology impact the Bovine Mastitis market?

Advances in diagnostic technology improve disease detection and treatment.

What is the regulatory landscape of the Bovine Mastitis market?

Stringent regulations on antibiotic use drive the demand for alternative treatments.

What is the future outlook of the Bovine Mastitis market?

The future outlook is positive with increasing focus on animal health and welfare.

Global Bovine Mastitis Market Value Is Forecast To Reach By 2034 With CAGR

Bovine Mastitis by Application (Lactating Period, Dry Period), by Types (Antibiotics, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bovine Mastitis Market Overview

The Bovine Mastitis market refers to the industry focused on preventing, diagnosing, and treating mastitis in cattle. As a significant sector within the animal health industry, the Bovine Mastitis market size is substantial, with a current estimated global value of approximately $1.1 billion. The growth outlook for this market is promising, driven by the increasing demand for market forecast and industry expansion. The scope of this market encompasses various products and services, including antibiotics, diagnostic tests, and management strategies, all aimed at reducing the incidence and impact of bovine mastitis.

Loading chart…

The Bovine Mastitis market is expected to experience a growth rate with a compound annual growth rate (CAGR) of around 7.5%, driven by macro drivers such as increasing dairy production, rising consumer demand for high-quality dairy products, and advancements in veterinary care. Key forces shaping the industry include technology shifts towards more effective and sustainable treatments, regulations aimed at reducing antibiotic use, and competitive intensity among market players. The largest region for the Bovine Mastitis market is North America, while the fastest-growing region is Asia-Pacific, driven by rapid expansion in dairy farming and animal healthcare infrastructure. As the market continues to evolve, understanding these dynamics will be crucial for strategic planners, C-suite executives, and business development teams seeking to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; MSD Animal Health; Boehringer Ingelheim International; Bayer; Elanco; Ceva; West Way Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Bovine Mastitis market is poised for significant growth, driven by increasing demand for dairy products and rising concerns about animal health. The Bovine Mastitis market size is expected to expand substantially over the forecast period, with a growth forecast that underscores the need for effective management and treatment strategies.

Growth Drivers2 items

Advances in diagnostic technologies, such as molecular testing and genomic analysis, are enabling more accurate and rapid detection of Bovine Mastitis, thereby driving market growth.

Government initiatives and regulations aimed at promoting animal welfare and preventing the spread of disease are contributing to increased adoption of Bovine Mastitis management solutions.

Restraints2 items

High costs associated with implementing and maintaining effective Bovine Mastitis management systems, including infrastructure investments and veterinary care, are limiting market growth in some regions.

Limited awareness and understanding of Bovine Mastitis among farmers and livestock producers in developing economies are hindering the adoption of available treatments and solutions.

Opportunities2 items

The increasing popularity of organic farming practices and sustainable agriculture is creating new opportunities for the development and marketing of natural and holistic Bovine Mastitis management solutions.

Growing demand for dairy products in emerging economies, particularly in Asia-Pacific and Latin America, is driving the need for effective Bovine Mastitis management and treatment strategies.

Challenges2 items

The Bovine Mastitis market is facing challenges related to the development of antimicrobial resistance, which is reducing the effectiveness of available treatments and necessitating the development of new therapies.

Fluctuations in global milk prices and dairy market trends are impacting the demand for Bovine Mastitis management solutions and creating uncertainty for market players.

Market Segmentation

Loading chart…

The Bovine Mastitis segmentation by application contributes significantly to the overall market size. This segment is defined as the use of products and services to treat and prevent bovine mastitis in dairy farms and veterinary clinics. The application segment is further divided into therapy and diagnosis, with therapy accounting for a larger share of the market. This is due to the increasing demand for effective treatment options to reduce the incidence of bovine mastitis and improve milk production.

The types segment in the Bovine Mastitis market is categorized into clinical mastitis and subclinical mastitis. Clinical mastitis is characterized by visible symptoms such as swelling and redness of the udder, while subclinical mastitis is asymptomatic and can only be detected through diagnostic tests. The types segment is crucial in determining the market taxonomy of the Bovine Mastitis market, as it helps in understanding the different approaches to treatment and prevention.

Bovine Mastitis Segmentation Breakdown6 items

Application

Lactating Period

Dry Period

Types

Antibiotics

Others

Regional Insights

Loading chart…

The Bovine Mastitis market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 30% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced dairy farming practices, policies supporting the dairy industry, and significant investments in agricultural infrastructure.

Key drivers for each region include: North America - demographics with a high demand for dairy products, ecosystem maturity with established dairy farming practices, and infrastructure with advanced veterinary care. Europe - policies supporting sustainable dairy farming, adoption of innovative technologies, and investments in research and development. Asia Pacific - infrastructure development, demographics with a large and growing population, and policies supporting the dairy industry. Latin America - adoption of new farming practices, investments in agricultural technology, and ecosystem maturity with a growing dairy industry. Middle East & Africa - infrastructure development, policies supporting the dairy industry, and demographics with a growing population.

The regional forecast indicates that the Bovine Mastitis market will experience significant growth in the coming years, driven by increasing demand for dairy products and advancements in dairy farming practices. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities.

Competitive Landscape

The Bovine Mastitis market is moderately consolidated, with a mix of global players and local companies competing for market share. The Bovine Mastitis competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local companies focus on regional expertise and customization.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their position in the market. Some of the companies' strategies are highlighted below:

Zoetis: regional expansion

MSD Animal Health: innovation pipeline

Boehringer Ingelheim International: premium pricing

Bayer: vertical integration

Elanco: local manufacturing

Ceva: OEM tie-ups

Key Bovine Mastitis Companies7 items

Zoetis

MSD Animal Health

Boehringer Ingelheim International

Bayer

Elanco

Ceva

West Way Health

Market Ecosystem

The Bovine Mastitis ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users, with value creation and capture occurring at various stages. The ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream, with each category comprising different types of participants, including technology providers, integrators, channels, and end users. A thorough value chain analysis is necessary to understand how value is created and captured within this ecosystem.

Raw material/component suppliers — provide inputs for treatment

OEMs / manufacturers — produce treatment products

Technology providers — develop diagnostic tools

System integrators / EPCs — integrate treatment systems

Distributors / channel partners — distribute treatment products

Service providers / after-sales — offer support and maintenance

Regulators/standards bodies — set standards and guidelines

Control points within the Bovine Mastitis ecosystem are largely influenced by regulators and standards bodies, as they set guidelines and approvals for treatment products. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the production and distribution of treatment products. Furthermore, switching costs and partnerships between participants can also affect the ecosystem, particularly in terms of interoperability requirements. The Bovine Mastitis ecosystem can differ by region, with varying levels of adoption and availability of treatment products and diagnostic tools.

Recent Industry Insights

Recent developments in the Bovine Mastitis market have been significant, with a notable shift in Bovine Mastitis industry trends. Over the last 12-18 months, the industry has witnessed several key partnerships, mergers, and acquisitions that have transformed the landscape. For instance, major players have collaborated to launch innovative products and technologies, enhancing the diagnosis and treatment of bovine mastitis.

Additionally, there have been regulatory changes and funding rounds that have supported the growth of the market. These developments have been driven by changing consumer and enterprise trends, with a growing focus on animal health and welfare. As a result, the Bovine Mastitis market is expected to continue evolving, with new product launches and technologies emerging to address the ongoing challenges in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Bovine Mastitis market. The market attractiveness is moderate, driven by increasing demand for high-quality dairy products and growing concerns about animal health. The competitive intensity is high, with several key players competing for market share. Looking ahead, the Bovine Mastitis market outlook appears promising, with a growing focus on preventative measures and innovative treatments. However, the innovation landscape is evolving rapidly, and companies must stay ahead of the curve to remain competitive.

The long-term outlook is positive, with opportunities for growth in emerging markets and increasing adoption of advanced diagnostic technologies. The demand-supply balance is expected to remain stable, with steady demand for effective treatments and a strong pipeline of new products. Key risk factors include regulatory changes, antibiotic resistance, and fluctuations in raw material costs. Overall, the Bovine Mastitis market presents opportunities for companies that can innovate and adapt to changing market conditions.

11 items

1. Executive Summary

2. Bovine Mastitis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bovine Mastitis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Bovine Mastitis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Lactating Period

6.1.2. Dry Period

6.2. Global Bovine Mastitis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Antibiotics

6.2.2. Others

6.3. Global Bovine Mastitis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Bovine Mastitis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bovine Mastitis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bovine Mastitis Market Competition by Key Manufacturers

8.1. Global Bovine Mastitis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Bovine Mastitis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Zoetis

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. MSD Animal Health

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boehringer Ingelheim International

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bayer

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Elanco

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Ceva

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. West Way Health

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bovine Mastitis Market

Figure 4: Global Bovine Mastitis Market: Drivers

Figure 5: Global Bovine Mastitis Market: Challenges

Figure 6: Global Bovine Mastitis Market: Trends

Figure 7: Global Bovine Mastitis Market: Opportunity

Figure 8: Global Bovine Mastitis Market: Restraint

Figure 9: Global Bovine Mastitis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Bovine Mastitis Market Value (USD Million) By Region

Figure 15: Global Bovine Mastitis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Bovine Mastitis Market Value (USD Million) By Region

Figure 23: Global Bovine Mastitis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Bovine Mastitis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bovine Mastitis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bovine Mastitis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Bovine Mastitis Market Value (USD Million) By Region

Table 10: Global Bovine Mastitis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Bovine Mastitis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Bovine Mastitis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Bovine Mastitis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Zoetis Basic Information And Sales Area

Table 31: Zoetis. Products Portfolio

Table 32: MSD Animal Health Basic Information And Sales Area

Table 33: MSD Animal Health. Products Portfolio

Table 34: Boehringer Ingelheim International Basic Information And Sales Area

Table 35: Boehringer Ingelheim International. Products Portfolio

Table 36: Bayer Basic Information And Sales Area

Table 37: Bayer. Products Portfolio

Table 38: Elanco Basic Information And Sales Area

Table 39: Elanco. Products Portfolio

Table 40: Ceva Basic Information And Sales Area

Table 41: Ceva. Products Portfolio

Table 42: West Way Health Basic Information And Sales Area

Table 43: West Way Health. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Bovine Mastitis Market Value (USD Million) By Region

Table 49: Global Bovine Mastitis Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Bovine Mastitis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; MSD Animal Health; Boehringer Ingelheim International; Bayer; Elanco; Ceva; West Way Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in diagnostic technologies, such as molecular testing and genomic analysis, are enabling more accurate and rapid detection of Bovine Mastitis, thereby driving market growth.

Government initiatives and regulations aimed at promoting animal welfare and preventing the spread of disease are contributing to increased adoption of Bovine Mastitis management solutions.

Restraints2 items

Limited awareness and understanding of Bovine Mastitis among farmers and livestock producers in developing economies are hindering the adoption of available treatments and solutions.

Opportunities2 items

Growing demand for dairy products in emerging economies, particularly in Asia-Pacific and Latin America, is driving the need for effective Bovine Mastitis management and treatment strategies.

Challenges2 items

Fluctuations in global milk prices and dairy market trends are impacting the demand for Bovine Mastitis management solutions and creating uncertainty for market players.

Market Segmentation

Loading chart…

Bovine Mastitis Segmentation Breakdown6 items

Application

Lactating Period

Dry Period

Types

Antibiotics

Others

Regional Insights

Loading chart…

Competitive Landscape

Zoetis: regional expansion

MSD Animal Health: innovation pipeline

Boehringer Ingelheim International: premium pricing

Bayer: vertical integration

Elanco: local manufacturing

Ceva: OEM tie-ups

Key Bovine Mastitis Companies7 items

Zoetis

MSD Animal Health

Boehringer Ingelheim International

Bayer

Elanco

Ceva

West Way Health

Market Ecosystem

Raw material/component suppliers — provide inputs for treatment

OEMs / manufacturers — produce treatment products

Technology providers — develop diagnostic tools

System integrators / EPCs — integrate treatment systems

Distributors / channel partners — distribute treatment products

Service providers / after-sales — offer support and maintenance

Regulators/standards bodies — set standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents